Global Intelligent Clinical Trials Industry

2023-2029 Global Intelligent Clinical Trials Industry Research & Trends Analysis Report

Global Intelligent Clinical Trials Industry

2023-2029 Global Intelligent Clinical Trials Industry Research & Trends Analysis Report

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to the research report published by Market IntelliX, the global market for Intelligent Clinical Trials should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Intelligent Clinical Trials market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Intelligent Clinical Trials market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Interventional segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Autoimmune/Inflammation has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Intelligent Clinical Trials include Cerner Corporation, GE Healthcare, Koninklijke Philips N.V., Cognizant, McKesson Corporation, Athenahealth, Veradigm, Navitas Life Sciences and Medidata Acorn AI, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Artificial intelligence can reduce clinical trial cycle times while improving the costs of productivity and outcomes of clinical development.

This report aims to provide a comprehensive study of the global market for Intelligent Clinical Trials. Report Highlights:

(1) Global Intelligent Clinical Trials market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Intelligent Clinical Trials market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Intelligent Clinical Trials market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Intelligent Clinical Trials segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Intelligent Clinical Trials segment by type and by application and regional segment by type and by application.

(6) Intelligent Clinical Trials industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Interventional

Observational

Expanded Access

Others

Market segment by application, can be divided into

Autoimmune/Inflammation

Pain Management

Oncology

Central Nervous System (CNS) Condition

Diabetes

Obesity

Cardiovascular

Others

Market segment by players, this report covers

Cerner Corporation

GE Healthcare

Koninklijke Philips N.V.

Cognizant

McKesson Corporation

Athenahealth

Veradigm

Navitas Life Sciences

Medidata Acorn AI

Accenture

1 Market Overview

1.1 Product Overview and Scope of Intelligent Clinical Trials

1.2 Global Intelligent Clinical Trials Market Size and Forecast

1.3 China Intelligent Clinical Trials Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Intelligent Clinical Trials Share in Global Market, 2018-2029

1.4.2 Intelligent Clinical Trials Market Size: China VS Global, 2018-2029

1.5 Intelligent Clinical Trials Market Dynamics

1.5.1 Intelligent Clinical Trials Market Drivers

1.5.2 Intelligent Clinical Trials Market Restraints

1.5.3 Intelligent Clinical Trials Industry Trends

1.5.4 Intelligent Clinical Trials Industry Policy

2 Global Competitive Situation by Company

2.1 Global Intelligent Clinical Trials Revenue by Company (2018-2023)

2.2 Global Intelligent Clinical Trials Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Intelligent Clinical Trials Concentration Ratio

2.4 Global Intelligent Clinical Trials Mergers & Acquisitions, Expansion Plans

2.5 Global Intelligent Clinical Trials Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Intelligent Clinical Trials Revenue by Company (2018-2023)

3.2 China Intelligent Clinical Trials Intelligent Clinical Trials Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Intelligent Clinical Trials, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Intelligent Clinical Trials Industry Chain

4.2 Intelligent Clinical Trials Upstream Analysis

4.3 Intelligent Clinical Trials Midstream Analysis

4.4 Intelligent Clinical Trials Downstream Analysis

5 Sights by Type

5.1 Intelligent Clinical Trials Classification

5.1.1 Interventional

5.1.2 Observational

5.1.3 Expanded Access

5.1.4 Others

5.2 By Type, Global Intelligent Clinical Trials Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Intelligent Clinical Trials Revenue, 2018-2029

6 Sights by Application

6.1 Intelligent Clinical Trials Segment by Application

6.1.1 Autoimmune/Inflammation

6.1.2 Pain Management

6.1.3 Oncology

6.1.4 Central Nervous System (CNS) Condition

6.1.5 Diabetes

6.1.6 Obesity

6.1.7 Cardiovascular

6.1.8 Others

6.2 By Application, Global Intelligent Clinical Trials Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Intelligent Clinical Trials Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Intelligent Clinical Trials Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Intelligent Clinical Trials Market Size, 2018-2029

7.3 North America

7.3.1 North America Intelligent Clinical Trials Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Intelligent Clinical Trials Market Size Market Share

7.4 Europe

7.4.1 Europe Intelligent Clinical Trials Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Intelligent Clinical Trials Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Intelligent Clinical Trials Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Intelligent Clinical Trials Market Size Market Share

7.6 South America

7.6.1 South America Intelligent Clinical Trials Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Intelligent Clinical Trials Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Intelligent Clinical Trials Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Intelligent Clinical Trials Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Intelligent Clinical Trials Market Size, 2018-2029

8.3.2 By Company, U.S. Intelligent Clinical Trials Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Intelligent Clinical Trials Market Size, 2018-2029

8.4.2 By Company, Europe Intelligent Clinical Trials Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Intelligent Clinical Trials Market Size, 2018-2029

8.5.2 By Company, China Intelligent Clinical Trials Revenue Market Share, 2018-2023

8.5.3 By Type, China Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Intelligent Clinical Trials Market Size, 2018-2029

8.6.2 By Company, Japan Intelligent Clinical Trials Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Intelligent Clinical Trials Market Size, 2018-2029

8.7.2 By Company, South Korea Intelligent Clinical Trials Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Intelligent Clinical Trials Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Intelligent Clinical Trials Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Intelligent Clinical Trials Market Size, 2018-2029

8.9.2 By Company, India Intelligent Clinical Trials Revenue Market Share, 2018-2023

8.9.3 By Type, India Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Intelligent Clinical Trials Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Intelligent Clinical Trials Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Intelligent Clinical Trials Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Cerner Corporation

9.1.1 Cerner Corporation Company Information, Head Office, Market Area and Industry Position

9.1.2 Cerner Corporation Company Profile and Main Business

9.1.3 Cerner Corporation Intelligent Clinical Trials Models, Specifications and Application

9.1.4 Cerner Corporation Intelligent Clinical Trials Revenue and Gross Margin, 2018-2023

9.1.5 Cerner Corporation Recent Developments

9.2 GE Healthcare

9.2.1 GE Healthcare Company Information, Head Office, Market Area and Industry Position

9.2.2 GE Healthcare Company Profile and Main Business

9.2.3 GE Healthcare Intelligent Clinical Trials Models, Specifications and Application

9.2.4 GE Healthcare Intelligent Clinical Trials Revenue and Gross Margin, 2018-2023

9.2.5 GE Healthcare Recent Developments

9.3 Koninklijke Philips N.V.

9.3.1 Koninklijke Philips N.V. Company Information, Head Office, Market Area and Industry Position

9.3.2 Koninklijke Philips N.V. Company Profile and Main Business

9.3.3 Koninklijke Philips N.V. Intelligent Clinical Trials Models, Specifications and Application

9.3.4 Koninklijke Philips N.V. Intelligent Clinical Trials Revenue and Gross Margin, 2018-2023

9.3.5 Koninklijke Philips N.V. Recent Developments

9.4 Cognizant

9.4.1 Cognizant Company Information, Head Office, Market Area and Industry Position

9.4.2 Cognizant Company Profile and Main Business

9.4.3 Cognizant Intelligent Clinical Trials Models, Specifications and Application

9.4.4 Cognizant Intelligent Clinical Trials Revenue and Gross Margin, 2018-2023

9.4.5 Cognizant Recent Developments

9.5 McKesson Corporation

9.5.1 McKesson Corporation Company Information, Head Office, Market Area and Industry Position

9.5.2 McKesson Corporation Company Profile and Main Business

9.5.3 McKesson Corporation Intelligent Clinical Trials Models, Specifications and Application

9.5.4 McKesson Corporation Intelligent Clinical Trials Revenue and Gross Margin, 2018-2023

9.5.5 McKesson Corporation Recent Developments

9.6 Athenahealth

9.6.1 Athenahealth Company Information, Head Office, Market Area and Industry Position

9.6.2 Athenahealth Company Profile and Main Business

9.6.3 Athenahealth Intelligent Clinical Trials Models, Specifications and Application

9.6.4 Athenahealth Intelligent Clinical Trials Revenue and Gross Margin, 2018-2023

9.6.5 Athenahealth Recent Developments

9.7 Veradigm

9.7.1 Veradigm Company Information, Head Office, Market Area and Industry Position

9.7.2 Veradigm Company Profile and Main Business

9.7.3 Veradigm Intelligent Clinical Trials Models, Specifications and Application

9.7.4 Veradigm Intelligent Clinical Trials Revenue and Gross Margin, 2018-2023

9.7.5 Veradigm Recent Developments

9.8 Navitas Life Sciences

9.8.1 Navitas Life Sciences Company Information, Head Office, Market Area and Industry Position

9.8.2 Navitas Life Sciences Company Profile and Main Business

9.8.3 Navitas Life Sciences Intelligent Clinical Trials Models, Specifications and Application

9.8.4 Navitas Life Sciences Intelligent Clinical Trials Revenue and Gross Margin, 2018-2023

9.8.5 Navitas Life Sciences Recent Developments

9.9 Medidata Acorn AI

9.9.1 Medidata Acorn AI Company Information, Head Office, Market Area and Industry Position

9.9.2 Medidata Acorn AI Company Profile and Main Business

9.9.3 Medidata Acorn AI Intelligent Clinical Trials Models, Specifications and Application

9.9.4 Medidata Acorn AI Intelligent Clinical Trials Revenue and Gross Margin, 2018-2023

9.9.5 Medidata Acorn AI Recent Developments

9.10 Accenture

9.10.1 Accenture Company Information, Head Office, Market Area and Industry Position

9.10.2 Accenture Company Profile and Main Business

9.10.3 Accenture Intelligent Clinical Trials Models, Specifications and Application

9.10.4 Accenture Intelligent Clinical Trials Revenue and Gross Margin, 2018-2023

9.10.5 Accenture Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Global Intelligent Clinical Trials Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Is the Global Intelligent Clinical Trials Market shifting its focus from growth to value?
Recognize the areas along the Global Intelligent Clinical Trials Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
What are the major applications for Global Intelligent Clinical Trials?
Global Intelligent Clinical Trials has a wide range of applications, including and others.
What is the current state of the Global Intelligent Clinical Trials Industry, and what is the projected growth trajectory through 2030?
In 2024, the Global Intelligent Clinical Trials Market share surpassed USD xx million, and between 2025 and 2030, it will grow at a CAGR of yy%.
What is really changing the Global Intelligent Clinical Trials Market behavior?
Consumer behavior changes will reshape the entire decision-making process and companies in the Global Intelligent Clinical Trials Industry will need to adapt quickly.
Who should consider the Global Intelligent Clinical Trials Market study?
The Global Intelligent Clinical Trials Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.